DMAC — DiaMedica Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00
- $97.55m
- $44.66m
- 42
- 26
- 64
- 40
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 7.88 | 27.5 | 45.1 | 33.5 | 52.9 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.823 | 0.34 | 0.13 | 0.082 | 0.369 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 8.84 | 27.9 | 45.4 | 33.8 | 53.7 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.217 | 0.174 | 0.112 | 0.56 | 0.485 |
Other Long Term Assets | |||||
Total Assets | 9.05 | 28.1 | 45.6 | 34.4 | 54.2 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Current Liabilities | 1.32 | 2.03 | 1.52 | 2.17 | 2.79 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 1.44 | 2.08 | 1.53 | 2.57 | 3.1 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 7.62 | 26 | 44 | 31.8 | 51.1 |
Total Liabilities & Shareholders' Equity | 9.05 | 28.1 | 45.6 | 34.4 | 54.2 |
Total Common Shares Outstanding |